0001757610-23-000001.txt : 20230302 0001757610-23-000001.hdr.sgml : 20230302 20230302102017 ACCESSION NUMBER: 0001757610-23-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230302 DATE AS OF CHANGE: 20230302 EFFECTIVENESS DATE: 20230302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Zyus Life Sciences Inc. CENTRAL INDEX KEY: 0001757610 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: A9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-474660 FILM NUMBER: 23696881 BUSINESS ADDRESS: STREET 1: 407 DOWNEY RD STREET 2: SUITE 204 CITY: SASKATOON STATE: A9 ZIP: SLN4L8 BUSINESS PHONE: 306-651-7711 MAIL ADDRESS: STREET 1: 407 DOWNEY RD STREET 2: SUITE 204 CITY: SASKATOON STATE: A9 ZIP: SLN4L8 FORMER COMPANY: FORMER CONFORMED NAME: CB3 Life Sciences Ltd. DATE OF NAME CHANGE: 20181030 D 1 primary_doc.xml X0708 D LIVE 0001757610 Zyus Life Sciences Inc. 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA SLN4L8 306-651-7711 SASKATCHEWAN, CANADA CB3 Life Sciences Ltd. Corporation true 2018 Keith Carpenter 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Strategy Officer Brent Zettl 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Executive Officer John Knowles 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Richard Hoyt 407 DOWNEY RD SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director John Hyshka 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Financial Officer Garnette Weber 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Director Dr. Lionel Marks de Chabris 407 DOWNEY RD SUITE 204 SASKATOON A9 SASKATCHEWAN, CANADA S7N 4L8 Executive Officer Chief Medical Officer Other Health Care Decline to Disclose 06b false 2023-02-16 false true true false 0 1484600 18557 1466043 The issuer is a Canadian and the balance of the "total remaining to be sold" has been sold to Canadian investors. false 1 0 0 0 false Zyus Life Sciences Inc. /Brent Zettl/ Brent Zettl President and CEO 2023-03-02